MUC17-positive Solid Tumors

Clinical trial pipeline · Data from ClinicalTrials.gov

See which MUC17-positive Solid Tumors trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 1

NCT04117958

Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal,…

To evaluate the safety and tolerability of AMG 199 in adult subjects and to determine the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D).

United States, Austria, France58 participantsStarted 2020-01-20

Treatment: AMG 199